Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Small Cell Lung Cancer Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01320059
What this trial is testing

Study of 18F-Fluoro-PEG6-IPQA

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 6
Post-approval studies (Phase 4)Looking for participantsNCT07357597
What this trial is testing

An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.

Who this might be right for
Stomatitis
AstraZeneca 100
Testing effectiveness (Phase 2)Study completedNCT05975073
What this trial is testing

Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

Who this might be right for
MTAP-null Non-Small-Cell Lung CancerMTAP-null Solid Tumors
Amgen 53
Testing effectiveness (Phase 2)Study completedNCT00364780
What this trial is testing

Study of XL647 in Subjects With Non-Small-Cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
Kadmon Corporation, LLC 55
Testing effectiveness (Phase 2)Study completedNCT00551369
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 33
Testing effectiveness (Phase 2)Study completedNCT00010218
What this trial is testing

Karenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 55
Large-scale testing (Phase 3)Looking for participantsNCT07100080
What this trial is testing

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 500
Post-approval studies (Phase 4)Study completedNCT02316327
What this trial is testing

Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Fundacion Clinic per a la Recerca Biomédica 19
Testing effectiveness (Phase 2)UnknownNCT05141786
What this trial is testing

MRG002 in the Treatment of Patients With HER2-mutated Unresectable/Metastatic Non-small Cell Lung Cancer (NSCLC).

Who this might be right for
Non-small- Cell Lung Cancer (NSCLC)
Shanghai Miracogen Inc. 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03474497
What this trial is testing

UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade

Who this might be right for
Non Small Cell Lung CancerMetastatic MelanomaMetastatic Renal Cell Carcinoma+1 more
Megan Daly, MD 18
Large-scale testing (Phase 3)Study completedNCT01951482
What this trial is testing

Pemetrexed/Platinum With or Without Bevacizumab in Brain Metastases From Patients With EGFR/ALK Negative Non-Squamous Non-small Cell Lung Cancer

Who this might be right for
Non Squamous Non-small Cell Lung CancerBrain MetastasesBevacizumab
Sun Yat-sen University 160
Large-scale testing (Phase 3)Not Yet RecruitingNCT06858410
What this trial is testing

Lorlatinib Compared with Concurrent/ Sequential Chemoradiotherapy in Stage III ALK Positive Lung Adenocarcinoma

Who this might be right for
Neoadjuvant Non-Small Cell Lung Cancer
Guangdong Association of Clinical Trials 36
Testing effectiveness (Phase 2)Study completedNCT03583086
What this trial is testing

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

Who this might be right for
Thymic CarcinomaNon-small Cell Lung CancerRefractory Thoracic Tumors+1 more
Vanderbilt-Ingram Cancer Center 88
Large-scale testing (Phase 3)UnknownNCT00273494
What this trial is testing

Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2

Who this might be right for
Non-Small Cell Lung Cancer
Rigshospitalet, Denmark 406
Testing effectiveness (Phase 2)Active Not RecruitingNCT05894889
What this trial is testing

Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC

Who this might be right for
Stage IIIB(N2) Non-small Cell Lung CancerStage IIA Non-small Cell Lung CancerStage IIB Non-small Cell Lung Cancer+1 more
Peking University 70
Early research (Phase 1)Study completedNCT01295827
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)

Who this might be right for
Cancer, Solid Tumor
Merck Sharp & Dohme LLC 1,260
Testing effectiveness (Phase 2)UnknownNCT02037997
What this trial is testing

Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Fudan University 80
Testing effectiveness (Phase 2)UnknownNCT02884479
What this trial is testing

An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study

Who this might be right for
Advanced Solid TumorNon-Small Cell Lung Cancer
SciClone Pharmaceuticals International (Cayman) Development Limited 75
Early research (Phase 1)Study completedNCT01840579
What this trial is testing

Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011)

Who this might be right for
Solid TumorNon-small Cell Lung CancerSmall Cell Lung Cancer
Merck Sharp & Dohme LLC 57
Not applicableUnknownNCT04306094
What this trial is testing

Factors Determining the Prognosis in NSCLC Stage IV

Who this might be right for
NSCLC Stage IV
Instituto do Cancer do Estado de São Paulo 217
Next Page